Page 11 - Gb Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(1) LAS VEGAS, NV / ACCESSWIRE / January 25, 2021 / GB Sciences, Inc. (OTCQB:GBLX), through GBS Global Biopharma, Inc. ("GBS"), has executed a Sponsored Research Agreement with Michigan State University (MSU) to obtain valuable proof-of-concept data to support the use of their new proprietary cannabinoid containing complex mixtures (CCCM) for the treatment of Cytokine Release Syndrome (CRS) and associated hyperinflammatory conditions such as macrophage activation syndrome (MAS) and acute respiratory distress syndrome (ARDS) in COVID-19 patients. CRS, MAS, and ARDS are the leading causes of d...

(1) LAS VEGAS, NV / ACCESSWIRE / January 12, 2021 / GB Sciences, Inc. (OTCQB:GBLX) completed the sale of its remaining interest in GB Sciences Louisiana LLC ("GBSLA") on December 16, 2020. In November 2019, the Company entered into a Membership Interest Purchase Agreement (the "Agreement") with Wellcana Plus, LLC ("Wellcana"), whereby Wellcana would acquire the Company's 50% membership interest in GBSLA. Since then, certain modifications of the Agreement had taken place so GB Sciences would be paid a total of $4,900,000: $4,150,000 in one lump sum at closing, in addition to the $750,000 alre...

The U.S. Drug Enforcement Administration is poised to issue licenses for the cultivation of cannabis for research purposes in the first half of the next year. The agency is expanding the number of licensed cannabis cultivators for research up from the country's sole producer of marijuana for research.  “DEA believes a range of three to 15 growers is a reasonable estimate for purposes of this economic analyses, with the understanding that the actual number could vary considerably,” the newly published rule says. The University of Mississippi is the only entity with the right to grow mar...